clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Tuberculosis, Ocular D014392 1 associated lipids
Encephalomyelitis, Acute Disseminated D004673 1 associated lipids
Empyema, Tuberculous D004654 1 associated lipids
Serositis D012700 1 associated lipids
Euthyroid Sick Syndromes D005067 1 associated lipids
Immune Reconstitution Inflammatory Syndrome D054019 1 associated lipids
Glossitis, Benign Migratory D005929 1 associated lipids
Parotid Diseases D010305 1 associated lipids
Sacroiliitis D058566 1 associated lipids
Achlorhydria D000126 1 associated lipids
Extensively Drug-Resistant Tuberculosis D054908 1 associated lipids
Pseudomyxoma Peritonei D011553 1 associated lipids
Eye Infections D015817 1 associated lipids
Upper Extremity Deep Vein Thrombosis D056824 1 associated lipids
Gastritis, Hypertrophic D005758 1 associated lipids
Buruli Ulcer D054312 1 associated lipids
Hypoproteinemia D007019 1 associated lipids
Myxoma D009232 1 associated lipids
Tuberculosis, Spinal D014399 1 associated lipids
Cutaneous Fistula D017577 1 associated lipids
Kleine-Levin Syndrome D017593 1 associated lipids
Granuloma, Plasma Cell D006104 1 associated lipids
Epilepsy, Partial, Motor D020938 1 associated lipids
Periodontal Abscess D010508 2 associated lipids
Cytomegalovirus Retinitis D017726 2 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Iritis D007500 2 associated lipids
Parotid Neoplasms D010307 2 associated lipids
IgA Deficiency D017098 2 associated lipids
Still's Disease, Adult-Onset D016706 2 associated lipids
Monoclonal Gammopathy of Undetermined Significance D008998 2 associated lipids
Eye Injuries, Penetrating D015807 2 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Leprosy, Lepromatous D015440 2 associated lipids
Discitis D015299 2 associated lipids
Iris Diseases D007499 2 associated lipids
Angiomatosis, Bacillary D016917 2 associated lipids
Tooth, Nonvital D019553 2 associated lipids
Tuberculosis, Avian D014379 2 associated lipids
Immunoproliferative Small Intestinal Disease D007161 2 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Cardiovascular Abnormalities D018376 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Leprosy, Paucibacillary D056005 2 associated lipids
Typhoid Fever D014435 2 associated lipids
Diphtheria D004165 2 associated lipids
Soft Tissue Infections D018461 2 associated lipids
Empyema, Pleural D016724 2 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Mastoiditis D008417 2 associated lipids
Tenosynovitis D013717 3 associated lipids
Pleuropneumonia D011001 3 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Peptic Ulcer Perforation D010439 3 associated lipids
Ureteral Diseases D014515 3 associated lipids
Sporotrichosis D013174 3 associated lipids
Fusobacterium Infections D005674 3 associated lipids
Ecchymosis D004438 3 associated lipids
Hernia, Hiatal D006551 3 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Keratoconjunctivitis D007637 3 associated lipids
Cryptogenic Organizing Pneumonia D018549 3 associated lipids
Bartonella Infections D001474 3 associated lipids
Paronychia D010304 3 associated lipids
Leprosy, Borderline D015439 3 associated lipids
Fractures, Open D005597 3 associated lipids
Psychophysiologic Disorders D011602 3 associated lipids
Scrub Typhus D012612 3 associated lipids
Barrett Esophagus D001471 3 associated lipids
Giardiasis D005873 3 associated lipids
Central Nervous System Protozoal Infections D020808 3 associated lipids
Empyema D004653 3 associated lipids
alpha 1-Antitrypsin Deficiency D019896 3 associated lipids
Eye Infections, Bacterial D015818 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Esophagitis, Peptic D004942 4 associated lipids
Gastritis, Atrophic D005757 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Common Variable Immunodeficiency D017074 4 associated lipids
Foot Diseases D005534 4 associated lipids
Chlamydophila Infections D023521 4 associated lipids
Ergotism D004881 4 associated lipids
Purpura, Thrombocytopenic, Idiopathic D016553 4 associated lipids
Rodent Diseases D012376 4 associated lipids
Dermatitis, Phototoxic D017484 4 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Peptic Ulcer Hemorrhage D010438 4 associated lipids
Pleural Diseases D010995 4 associated lipids
Parotitis D010309 4 associated lipids
Psittacosis D009956 4 associated lipids
Prurigo D011536 4 associated lipids
Confusion D003221 4 associated lipids
Lymphangitis D008205 4 associated lipids
Mycetoma D008271 4 associated lipids
Legionnaires' Disease D007877 4 associated lipids
Cysts D003560 4 associated lipids
Mycobacterium avium-intracellulare Infection D015270 4 associated lipids
Duodenitis D004382 4 associated lipids
Rickettsia Infections D012282 5 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Zhanel GG et al. Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia. 2006 Ther Clin Risk Manag pmid:18360582
Nawarskas JJ and Snowden SS Critical appraisal of ticagrelor in the management of acute coronary syndrome. 2011 Ther Clin Risk Manag pmid:22241944
Rafii F et al. Effects of treatment with antimicrobial agents on the human colonic microflora. 2008 Ther Clin Risk Manag pmid:19337440
Zhou S et al. Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4. 2005 Ther Clin Risk Manag pmid:18360537
Pace F et al. A review of rabeprazole in the treatment of acid-related diseases. 2007 Ther Clin Risk Manag pmid:18488081
Oncü S Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin. 2007 Ther Clin Risk Manag pmid:18488076
Duclos AJ et al. Current treatment options in the management of chronic prostatitis. 2007 Ther Clin Risk Manag pmid:18472971
Carrie AG and Marrie TJ Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department. 2005 Ther Clin Risk Manag pmid:18360543
Goodman JJ and Martin SI Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections. 2012 Ther Clin Risk Manag pmid:22547933
Werth S et al. Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery. 2012 Ther Clin Risk Manag pmid:22547932
Neely M and Kovacs A Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir. 2009 Ther Clin Risk Manag pmid:19707276
Niioka T et al. Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve. 2006 Ther Drug Monit pmid:16778714
Kunicki PK and Sobieszczańska-Małek M Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient. 2005 Ther Drug Monit pmid:15665756
Zhou SF et al. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. 2007 Ther Drug Monit pmid:18043468
Krause M [Resistance problems in gastrointestinal infections]. 2002 Ther Umsch pmid:11851045
Bohr UR and Malfertheiner P Eradication of H. pylori Infection: the Challenge is on if Standard Therapy Fails. 2009 Therap Adv Gastroenterol pmid:21180534
Berning M et al. Should quinolones come first in Helicobacter pylori therapy? 2011 Therap Adv Gastroenterol pmid:21694812
Mégraud F The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. 2012 Therap Adv Gastroenterol pmid:22423259
Gisbert JP Second-line rescue therapy of helicobacter pylori infection. 2009 Therap Adv Gastroenterol pmid:21180581
Pinzani V et al. [Occurrence of anterior uveitis in a HIV patient treated with rifabutin, ethambutol, clarithromycin]. 1995 Sep-Oct Therapie pmid:8571297
van Ingen J et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. 2009 Thorax pmid:19213773
Andréjak C et al. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. 2009 Thorax pmid:19052044
Essilfie AT et al. Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. 2015 Thorax pmid:25746630
Jenkins PA et al. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. 2008 Thorax pmid:18250184
Majoor CJ et al. Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. 2004 Thorax pmid:15223876
Spencer S and Jones PW Time course of recovery of health status following an infective exacerbation of chronic bronchitis. 2003 Thorax pmid:12832673
Brusselle GG Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases? 2015 Thorax pmid:25870311
Schweeger I et al. Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. 2000 Thromb. Res. pmid:10704650
Lygren I et al. [Treatment of Helicobacter pylori infection]. 1998 Tidsskr. Nor. Laegeforen. pmid:9889634
Farup PG [Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial]. 2003 Tidsskr. Nor. Laegeforen. pmid:14714012
Walrave TR et al. [Mania induced by antibiotic therapy]. Tijdschr Psychiatr pmid:27527887
Mukae H et al. Low expression of T-cell co-stimulatory molecules in bone marrow-derived dendritic cells in a mouse model of chronic respiratory infection with Pseudomonas aeruginosa. 2010 Tohoku J. Exp. Med. pmid:20046053
Kaji C et al. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. 2008 Tohoku J. Exp. Med. pmid:18285669
De Lorenzi G et al. Mycobacterium genavense Infection in a Domestic Ferret (Mustela putorius furo). 2018 Top Companion Anim Med pmid:30502861
Peters TS Do preclinical testing strategies help predict human hepatotoxic potentials? 2005 Toxicol Pathol pmid:15805066
Cosgrove BD et al. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. 2009 Toxicol. Appl. Pharmacol. pmid:19362101
Liu CN and Somps CJ Telithromycin blocks neuromuscular transmission and inhibits nAChR currents in vitro. 2010 Toxicol. Lett. pmid:20153815
Pedersen JM et al. Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11). 2013 Toxicol. Sci. pmid:24014644
Guo L et al. Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. 2013 Toxicol. Sci. pmid:24052561
Sawada H et al. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. 2005 Toxicol. Sci. pmid:15342952
Lin Z and Will Y Evaluation of drugs with specific organ toxicities in organ-specific cell lines. 2012 Toxicol. Sci. pmid:22166485
Jiang H et al. MLVA typing and antibiotic susceptibility of Brucella human isolates from Liaoning, China. 2010 Trans. R. Soc. Trop. Med. Hyg. pmid:20832094
Ani AE et al. Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria. 1999 Nov-Dec Trans. R. Soc. Trop. Med. Hyg. pmid:10717760
Baron BW et al. Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationship. 2003 Transfusion pmid:12919436
Ivetic Tkalcevic V et al. Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. 2012 Transl Res pmid:22677362
Korres DS et al. Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient. 2007 Transpl Infect Dis pmid:17313477
Chan A et al. A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient. 2012 Transpl Infect Dis pmid:22822725
Silva JT et al. Mycobacterium abscessus pulmonary infection complicated with vertebral osteomyelitis in a heart transplant recipient: case report and literature review. 2015 Transpl Infect Dis pmid:25816889
den Broeder AA et al. Disseminated Mycobacterium gordonae infection in a renal transplant recipient. 2003 Transpl Infect Dis pmid:14617305
Kim JE et al. Synchronous infection with Mycobacterium chelonae and Paecilomyces in a heart transplant patient. 2011 Transpl Infect Dis pmid:20412536